Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

132.00 USD +6.31 (+5.02%)
Streaming Delayed Price Updated: 12:27 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Crispr Therapeutics Ag

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MGNX ABBV NEO
From Benzinga
Biotech Stocks Rise After FDA Halts Test By Rival Blood Cancer Firm Cellectis
Biotech stocks such as Bluebird Bio mostly rose Tuesday after the FDA halted an innovative CAR-T blood cancer treatment test by potential competitor Cellectis after a patient died. 
From Investor's Business Daily
Stocks That Hit 52-Week Highs On Tuesday
Tuesday morning saw 90 companies set new 52-week highs. Intriguing Points: Apple(NASDAQ: AAPL)was the largest ... 
Tags BABA GFI SNAP
From Benzinga
These 3 Biotech Stocks Are Outperforming Their Peers — Here's Why
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth. 
From Investor's Business Daily
The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SYRS DXCM ADTX
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 218 companies set new 52-week highs. Facts of Interest: The company with the largest market ... 
Tags HCCH ZS NLS
From Benzinga
August 14th Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options begin trading today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech AMGN XBI
From Benzinga
51 Stocks Moving In Tuesday's Mid-Day Session
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares jumped 118% to $1.2750 after the company said that following a ... 
Tags EVSI ZYNE MKD
From Benzinga
The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks ... 
Tags REPL CRSP PCRX
From Benzinga
3 Reasons Why Vertex Is a Great Stock to Buy and Hold for the Long Term
Elements from the past, present, and future are reasons to be optimistic about this biotech star. 
Tags GILD Market News CRSP
From Motley Fool
33 Stocks Moving in Tuesday's Pre-Market Session
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) rose 70.6% to $0.9980 in pre-market trading after the company said the ... 
Tags OCX BNGO BOXL
From Benzinga
2 Top Gene-Editing Stocks to Buy Right Now
Both of these biotech companies recently released encouraging data from clinical trials. 
Tags CRSP Market News BMY
From Motley Fool
The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RNA LYRA NVO
From Benzinga
Why CRISPR Therapeutics Stock Just Popped Another 5%
Two bullish analyst recommendations in less than 24 hours boost the stock price more than 9%. 
Tags Market News CRSP VRTX
From Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 154 stocks made new 52-week highs. Significant Points: Microsoft(NASDAQ: MSFT)was the largest company ... 
Tags Building Products NVDA ALNY
From Benzinga
Where to Invest $1,000 If You're Worried the Stock Market Might Crash Again
Even if the market goes down, these investing options should go up. 
Tags VRTX CRSP TLT
From Motley Fool
Barron's Picks And Pans: Brunswick, Cloudflare, Gilead And More
This weekend's Barron's cover story at the high cost of income inequality. Other featured articles look to play the growing ... 
Tags BC Barron's Benzinga
From Benzinga
Biotech Leader Vertex Pharmaceuticals Offers New Buy Point After Key Support
Among the top stocks to watch, biotech leader Vertex Pharmaceuticals is approaching a new buy point after rebounding from a key support level. 
From Investor's Business Daily
Dow Jones Eases; Alteryx Crosses Buy Point, Enphase Hits This Sell Signal
On a portfolio-weighted basis, Leaderboard companies delivered a 77% gain from Jan. 1, 2017, to Dec. 31, 2019. 
From Investor's Business Daily
10 Biggest Price Target Changes For Monday
Citigroup raised Adobe Inc (NASDAQ: ADBE) price target from $293 to $413. Adobe shares closed at $406.54 on Friday. Piper Sandler ... 
Tags Apparel, Accessories & Luxury Goods Price Target Changes Analyst Ratings
From Benzinga
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics
Each company aims to use its genome editing platform to treat disease, but which has an edge? 
Tags BLUE Market News BIIB
From Motley Fool
CRISPR Therapeutics and Vertex Pharmaceuticals Deliever New CTX001 Data
The partners reported encouraging results from the first four patients treated with the CRISPR-based gene-editing therapy. 
Tags Market News CRSP VRTX
From Motley Fool
CRISPR Rally: The First Gene-Editing Drug Continues To Show Promise
Crispr Therapeutics and Vertex Pharmaceuticals stocks popped Friday after the biotech companies unveiled updated results for a gene-editing drug in blood-disease treatment. 
From Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AYLA FDA CALT
From Benzinga
Are These The Best Biotech Stocks To Buy Right Now?
From Stockmarket.com
July 31st Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the July 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
How IBD Stock Of The Day Vertex Launched A New Buying Opportunity
Cystic fibrosis treatment maker Vertex Pharmaceuticals is the IBD Stock Of The Day as shares bound into a new buy zone. Shares of VRTX stock bounded off their 50-day moving average. 
From Investor's Business Daily
The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage
The biotech space saw a flurry of activity last week, with coronavirus-related news, conference presentations and IPOs. Negative ... 
Tags Top Stories AGIO CRSP
From Benzinga
3 Top Biotech Stocks to Buy in June
They have one big thing in common: great growth prospects. 
Tags BMY VRTX ICPT
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback